NUVL

Insider trade Sale by Noci Darlene (Chief Development Officer)

18h ago

Insider trade Sale by Miller Deborah Ann (Chief Legal Officer)

18h ago

News Nuvalent granted FDA priority review for lung cancer therapy

6d ago

News Nuvalent Stock Jumps On ESMO Data Presentation, Seeks To Raise $350M Via Equity

14d ago

News Nuvalent GAAP EPS of -$1.39

26d ago

SEC filing NUVL Reports $1.2B Revenue, $0.08 EPS, NDA Submitted for Neladalkib, Zidesamtinib PDUFA Sep 18 2026, Label Expansion Planned H2 2026

26d ago

Insider trade Sale by James Richard Porter (President and CEO)

26d ago

Insider trade Sale by Alexandra Balcom (Chief Financial Officer)

27d ago

Insider trade Sale by Deborah Ann Miller (Chief Legal Officer)

31d ago

Insider trade Sale by Darlene Noci (Chief Development Officer)

31d ago

Insider trade Sale by Henry E. Pelish (Chief Scientific Officer)

49d ago

Insider trade Sale by James Richard Porter (President and CEO)

54d ago

Insider trade Sale by Henry E. Pelish (Chief Scientific Officer)

77d ago

Insider trade Sale by Deborah Ann Miller (Chief Legal Officer)

91d ago

Insider trade Sale by Darlene Noci (Chief Development Officer)

91d ago

News Biotech Fund Dumps $84 Million of Nuvalent With Stock Up 29%

99d ago

Insider trade Sale by Darlene Noci (Chief Development Officer)

104d ago

Insider trade Sale by Deborah Ann Miller

104d ago

News US Treasury chief warns China could challenge US digital asset lead via Hong Kong

116d ago

Scanner Unusual volume (z=3.1)

160d ago

Scanner Unusual volume (z=2.7)

161d ago

Scanner Unusual volume (z=2.7)

163d ago

Scanner Unusual volume (z=2.7)

164d ago

SEC filing NUVL Royalty Pharma Acquires $315M Royalty Interest in Cancer Drug Candidates, 1.5% Royalty Rate

168d ago